These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18815927)

  • 21. Genome-wide association studies in bladder cancer: first results and potential relevance.
    Kiemeney LA; Grotenhuis AJ; Vermeulen SH; Wu X
    Curr Opin Urol; 2009 Sep; 19(5):540-6. PubMed ID: 19553824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives on the molecular epidemiology of aerodigestive tract cancers.
    Hung RJ; van der Hel O; Tavtigian SV; Brennan P; Boffetta P; Hashibe M
    Mutat Res; 2005 Dec; 592(1-2):102-18. PubMed ID: 16023150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
    Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression.
    De Feo E; Persiani R; La Greca A; Amore R; Arzani D; Rausei S; D'Ugo D; Magistrelli P; van Duijn CM; Ricciardi G; Boccia S
    Mutat Res; 2009 Apr; 675(1-2):60-5. PubMed ID: 19386249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of whole-genome association scans in disease gene identification, drug discovery and development.
    Roses AD; St Jean PL; Ehm MG
    IDrugs; 2007 Nov; 10(11):797-804. PubMed ID: 17968762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
    Gangwar R; Mandhani A; Mittal RD
    Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
    Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
    Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of tumour necrosis factor-alpha gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guérin immunotherapy.
    Ahirwar DK; Mandhani A; Dharaskar A; Kesarwani P; Mittal RD
    BJU Int; 2009 Sep; 104(6):867-73. PubMed ID: 19338536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Colon cancer and nutritional genetics: modifier genes].
    Junien C
    Ann Med Interne (Paris); 2001 Sep; 152(5):337-51. PubMed ID: 11593147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.
    Habuchi T; Marberger M; Droller MJ; Hemstreet GP; Grossman HB; Schalken JA; Schmitz-Dräger BJ; Murphy WM; Bono AV; Goebell P; Getzenberg RH; Hautmann SH; Messing E; Fradet Y; Lokeshwar VB
    Urology; 2005 Dec; 66(6 Suppl 1):64-74. PubMed ID: 16399416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular epidemiology of lung cancer.
    Schwartz AG; Prysak GM; Bock CH; Cote ML
    Carcinogenesis; 2007 Mar; 28(3):507-18. PubMed ID: 17183062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population].
    Jin MJ; Liu B; Zhang SS; Zhang YJ; Xu M; Ma XY; Yao KY; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):535-9. PubMed ID: 19040031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving strategies for detecting genetic patterns of disease susceptibility in association studies.
    Calle ML; Urrea V; Vellalta G; Malats N; Steen KV
    Stat Med; 2008 Dec; 27(30):6532-46. PubMed ID: 18837071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.
    Srivastava A; Srivastava K; Pandey SN; Choudhuri G; Mittal B
    Ann Surg Oncol; 2009 Jun; 16(6):1695-703. PubMed ID: 19266243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.
    Synowiec E; Stefanska J; Morawiec Z; Blasiak J; Wozniak K
    Mutat Res; 2008 Dec; 648(1-2):65-72. PubMed ID: 18977234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of biomarkers to elucidate genetic susceptibility to cancer.
    Au WW; Salama SA
    Environ Mol Mutagen; 2005; 45(2-3):222-8. PubMed ID: 15690341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene polymorphisms in bladder cancer.
    Franekova M; Halasova E; Bukovska E; Luptak J; Dobrota D
    Urol Oncol; 2008; 26(1):1-8. PubMed ID: 18190823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular markers for detection, surveillance and prognostication of bladder cancer.
    Vrooman OP; Witjes JA
    Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.